Literature DB >> 350631

Ionic mechanisms of pacemaker activity in cardiac Purkinje fibers.

R W Tsien, D O Carpenter.   

Abstract

Rhythmic activity in cardiac Purkinje fibers can be analyzed by using the voltage clamp technique to study pacemaker currents. In normally polarized preparations, pacemaker activity can be generated by two distinct ionic mechanisms. The standard pacemaker potential (phase 4 depolarization) involves a slow potassium current, IK2. Following action potential repolarization, the IK2 channels slowly deactivate and thus unmask a steady background inward current. The resulting net inward current causes the slow pacemaker depolarization. Epinephrine accelerates the diastolic depolarization by promoting more complete and more rapid deactivation of IK2 over the pacemaker range of potentials. The catecholamine acts rather selectively on the voltage dependence of the gating mechanism, without altering the basic character of the pacemaker process. The nature of the pacemaker depolarization is altered by intoxication with high concentrations of cardiac glycosides or aglycones. These compounds promote spontaneous impulses in Purkinje fibers by a mechanism that supersedes the ordinary IK2 pacemaker. The digitalis-induced depolarization is generated by a transient inward current that is either absent or very small in untreated preparations. The transient inward current is largely carried by sodium ions. Its unusual time course probably reflects an underlying subcellular event, the oscillatory release of calcium ions from intracellular stores.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350631

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  11 in total

Review 1.  The road to biological pacing.

Authors:  Michael R Rosen; Richard B Robinson; Peter R Brink; Ira S Cohen
Journal:  Nat Rev Cardiol       Date:  2011-08-16       Impact factor: 32.419

2.  Periodic paralysis and ventricular tachycardia: possible role of calcium channel blockers.

Authors:  M R Ebeid; J L Baquero; H Gelband
Journal:  Pediatr Cardiol       Date:  1996 Jan-Feb       Impact factor: 1.655

3.  Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.

Authors:  H A Hallaq; G T Haupert
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Correlation between manifestations of digoxin toxicity and serum digoxin, calcium, potassium, and magnesium concentrations and arterial pH.

Authors:  M Sonnenblick; A S Abraham; Z Meshulam; U Eylath
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-02

5.  A study of pace-maker potential in rabbit sino-atrial node: measurement of potassium activity under voltage-clamp conditions.

Authors:  J Maylie; M Morad; J Weiss
Journal:  J Physiol       Date:  1981-02       Impact factor: 5.182

6.  Differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis.

Authors:  J C Somberg; W H Barry; T W Smith
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

7.  Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.

Authors:  R J Sung; W A Shapiro; E N Shen; F Morady; J Davis
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  The effect of verapamil on halothane-epinephrine or digitalis-induced ventricular dysrhythmias in dogs.

Authors:  Y Yoshizawa; R Shimizu; H Kasuda; S Akazawa; K Nemoto; S Inoue
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

9.  Release of adenine nucleotide metabolites by toxic concentrations of cardiac glycosides.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1994 Jul-Aug       Impact factor: 17.165

10.  Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.

Authors:  R J Sung; E C Keung; N X Nguyen; E C Huycke
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.